Automated analysis of atrial late gadolinium enhancement imaging that correlates with endocardial voltage and clinical outcomes: a 2-center study.
1184 - 1191
MetadataShow full item record
BACKGROUND: For late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) assessment of atrial scar to guide management and targeting of ablation in atrial fibrillation (AF), an objective, reproducible method of identifying atrial scar is required. OBJECTIVE: To describe an automated method for operator-independent quantification of LGE that correlates with colocated endocardial voltage and clinical outcomes. METHODS: LGE CMR imaging was performed at 2 centers, before and 3 months after pulmonary vein isolation for paroxysmal AF (n = 50). A left atrial (LA) surface scar map was constructed by using automated software, expressing intensity as multiples of standard deviation (SD) above blood pool mean. Twenty-one patients underwent endocardial voltage mapping at the time of pulmonary vein isolation (11 were redo procedures). Scar maps and voltage maps were spatially registered to the same magnetic resonance angiography (MRA) segmentation. RESULTS: The LGE levels of 3, 4, and 5SDs above blood pool mean were associated with progressively lower bipolar voltages compared to the preceding enhancement level (0.85 ± 0.33, 0.50 ± 0.22, and 0.38 ± 0.28 mV; P = .002, P < .001, and P = .048, respectively). The proportion of atrial surface area classified as scar (ie, >3 SD above blood pool mean) on preablation scans was greater in patients with postablation AF recurrence than those without recurrence (6.6% ± 6.7% vs 3.5% ± 3.0%, P = .032). The LA volume >102 mL was associated with a significantly greater proportion of LA scar (6.4% ± 5.9% vs 3.4% ± 2.2%; P = .007). CONCLUSIONS: LA scar quantified automatically by a simple objective method correlates with colocated endocardial voltage. Greater preablation scar is associated with LA dilatation and AF recurrence.
AuthorsMalcolme-Lawes, LC; Juli, C; Karim, R; Bai, W; Quest, R; Lim, PB; Jamil-Copley, S; Kojodjojo, P; Ariff, B; Davies, DW; Rueckert, D; Francis, DP; Hunter, R; Jones, D; Boubertakh, R; Petersen, SE; Schilling, R; Kanagaratnam, P; Peters, NS
- Cardiovascular 
Showing items related by title, author, creator and subject.
Catheter ablation of fractionated electrograms for atrial fibrillation: does it improve outcomes and can it be refined based on electrogram morphology or knowledge of the remodelling process?. Hunter, Ross J (Queen Mary University of London, 2013)Catheter ablation complex or fractionated atrial electrograms (CFAE) may improve outcomes for persistent AF. However, it is unclear whether CFAE are important in maintaining AF or whether targeting of CFAE can be refined ...
Patient safety and estimation of renal function in patients prescribed new oral anticoagulants for stroke prevention in atrial fibrillation: a cross-sectional study. Maccallum, PK; Mathur, R; Hull, SA; Saja, K; Green, L; Morris, JK; Ashman, N (2013)OBJECTIVE: In clinical trials of dabigatran and rivaroxaban for stroke prevention in atrial fibrillation (AF), drug eligibility and dosing were determined using the Cockcroft-Gault equation to estimate creatine clearance ...
Direct oral anti-coagulants for prevention of stroke and systemic embolism in non-valvular atrial fibrillation - Barts Health experience across two sites Kalkur, P; Kreze, O; Chauhan, N; Lim, S; Antoniou, S; MacCallum, P; Bowles, L (2015-04)